Zintis Inde

SU086, an inhibitor of HSP90, impairs glycolysis and represents a treatment strategy for advanced prostate cancer.

Rice MA, Kumar V, Tailor D, Garcia-Marques FJ, Hsu EC, Liu S, Bermudez A, Kanchustambham V, Shankar V, Inde Z, Alabi BR, Muruganantham A, Shen M, Pandrala M, Nolley R, Aslan M, Ghoochani A, Agarwal A, Buckup M, Kumar M, Going CC, Peehl DM, Dixon SJ, Zare RN, Brooks JD, Pitteri SJ, Malhotra SV, Stoyanova T.

Cell Rep Med. 2022 02 15. 3(2):100502. PMID: 35243415

Age-dependent regulation of SARS-CoV-2 cell entry genes and cell death programs correlates with COVID-19 severity.

Inde Z, Croker BA, Yapp C, Joshi GN, Spetz J, Fraser C, Qin X, Xu L, Deskin B, Ghelfi E, Webb G, Carlin AF, Zhu YP, Leibel SL, Garretson AF, Clark AE, Duran JM, Pretorius V, Crotty-Alexander LE, Li C, Lee JC, Sodhi C, Hackam DJ, Sun X, Hata AN, Kobzik L, Miller J, Park JA, Brownfield D, Jia H, Sarosiek KA.

Sci Adv. 2021 08. 7(34). PMID: 34407940

Quantification of drug-induced fractional killing using high-throughput microscopy.

Inde Z, Rodencal J, Dixon SJ.

STAR Protoc. 2021 03 19. 2(1):100300. PMID: 33532743

Age-dependent regulation of SARS-CoV-2 cell entry genes and cell death programs correlates with COVID-19 disease severity.

Inde Z, Yapp C, Joshi GN, Spetz J, Fraser C, Deskin B, Ghelfi E, Sodhi C, Hackam D, Kobzik L, Croker B, Brownfield D, Jia H, Sarosiek KA.

bioRxiv. 2020 Sep 13. PMID: 32935109

Kinetic Heterogeneity of Cancer Cell Fractional Killing.

Inde Z, Forcina GC, Denton K, Dixon SJ.

Cell Rep. 2020 07 07. 32(1):107845. PMID: 32640215

The impact of non-genetic heterogeneity on cancer cell death.

Inde Z, Dixon SJ.

Crit Rev Biochem Mol Biol. 2018 02. 53(1):99-114. PMID: 29250983

Initiation of Behavioral Response to Antidepressants by Cholecystokinin Neurons of the Dentate Gyrus.

Medrihan L, Sagi Y, Inde Z, Krupa O, Daniels C, Peyrache A, Greengard P.

Neuron. 2017 Aug 02. 95(3):564-576.e4. PMID: 28735749

Microdroplet sandwich real-time rt-PCR for detection of pandemic and seasonal influenza subtypes.

Angione SL, Inde Z, Beck CM, Artenstein AW, Opal SM, Tripathi A.

PLoS One. 2013. 8(9):e73497. PMID: 24066051

Targeting tumor-initiating cancer cells with dCD133KDEL shows impressive tumor reductions in a xenotransplant model of human head and neck cancer.

Waldron NN, Kaufman DS, Oh S, Inde Z, Hexum MK, Ohlfest JR, Vallera DA.

Mol Cancer Ther. 2011 Oct. 10(10):1829-38. PMID: 21862685